Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue April 2015
 •  Analysts Poke Holes in Lafley's Strategy  •  Estee Lauder Taps Eva Mendes  •  Scent Trends for 2016  •  Dollar Derails P&G  •  StriVectin Partners with mySkin Inc.
Print

KitoZyme Lands More Funding



Published April 4, 2013
Related Searches: executives chemistry active products
Post a comment
• KitoZyme has finalized a €9 million capital increase. The issue of new shares was reserved for and entirely underwritten by the company’s two main shareholders: Valois (Mestdagh Group and Montulet family) and SRIW, the Wallonia Regional Investment Company.

The move will significantly build the company’s equity and will allow it to actively continue developing new products and its international commercial expansion, according to company executives.
Based in Liège, Belgium, the company is active in the biochemistry and life sciences sectors, manufacturing biomass-derived biopolymers, non-animal chitosan, chitin-glucan and beta-glucan.


blog comments powered by Disqus